Tempest Therapeutics TPST
NASDAQ TPST
$0.53 0.00 (-0.29%)
As of: Oct 22, 2026 · 3:39 PM EDT

Tempest Therapeutics (TPST) Acquisitions (2018)

Updated

Tempest Therapeutics' Acquisitions came in at $524,000 for FY2018, compared with -$462,000 in FY2017.

Analysis

Tempest Therapeutics (TPST) Acquisitions (2018) Analysis & Trends

  • Per Business Quant, earlier years put Acquisitions at -$462,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,170.46 Bn 1,139.04 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 648.38 Bn 568.24 Bn 17.30 Bn -17.15 Bn
3 AbbVie 504.43 Bn 477.54 Bn 12.70 Bn -
4 Merck 367.73 Bn 322.11 Bn 12.21 Bn -
5 Novartis Ag 303.35 Bn 267.34 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 268.20 Bn 241.88 Bn 12.86 Bn -
7 Amgen 242.55 Bn 197.95 Bn 7.24 Bn -
8 Gilead Sciences 194.80 Bn 169.00 Bn 6.22 Bn 11.21 Bn
9 Pfizer 173.31 Bn 119.95 Bn 10.94 Bn -
10 Tempest Therapeutics 7.97 Mn -22.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 524,000.00
API Access

Tempest Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=TPST&period=max&api_key=YOUR_API_KEY